Skip to main content

Advertisement

SpringerLink
Log in

Telomerase as a tumor-associated antigen for cancer immunotherapy

  • Review
  • Published:
Cytotechnology Aims and scope Submit manuscript

Abstract

Telomerase reverse transcriptase hTERT is an attractive target for cancer immunotherapy given its broad expression in human tumors and its demonstrated immunogenicity. Human and murine model systems demonstrate that CD8+ cytotoxic T-lymphocytes (CTL) and CD4+ helper T-lymphocytes can recognize dominant epitopes derived from TERT. CTL kill TERT-positive tumor cells of multiple histologies, although there is some disagreement regarding the level of processing and presentation of certain TERT peptides within the context of MHC class I molecules. CTL recognizing modified, low-affinity cryptic TERT epitopes have also been generated that protect against tumor challenge in a murine model. Several phase I clinical trials testing hTERT as a cancer vaccine target have shown the induction of T-cell immune responses but minimal toxicities, including bone marrow toxicity, in patients with multiple types of cancer. Several studies report some patients experiencing clinical benefit, including partial tumor regression, providing further encouragement for hTERT as broadly applicable target for cancer immunotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

CTL:

cytotoxic T-lymphocyte

DC:

dendritic cells

HLA:

human leukocyte antigen

LAMP:

lysosome associated membrane protein

MHC:

major histocompatibility complex

TAA:

tumor-associated antigen

References

  • J. Arai M. Yasukawa H. Ohminami M. Kakimoto A. Hasegawa S. Fujita (2001) ArticleTitleIdentification of human telomerase reverse transcriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes Blood 97 2903–2907 Occurrence Handle10.1182/blood.V97.9.2903 Occurrence Handle11313288

    Article  PubMed  Google Scholar 

  • M. Ayyoub M. Migliaccio P. Guillaume D. Lienard J.C. Cerottini P. Romero F. Levy D.E. Speiser D. Valmori (2001) ArticleTitleLack of tumor recognition by hTERT peptide 540–548-specific CD8(+) T cells from melanoma patients reveals inefficient antigen processing Eur. J. Immunol. 31 2642–2651 Occurrence Handle10.1002/1521-4141(200109)31:9<2642::AID-IMMU2642>3.0.CO;2-6 Occurrence Handle11536162

    Article  PubMed  Google Scholar 

  • D. Broccoli J.W. Young T. de Lange (1995) ArticleTitleTelomerase activity in normal and malignant hematopoietic cells Proc. Natl. Acad. Sci. USA 92 9082–9086 Occurrence Handle7568077

    PubMed  Google Scholar 

  • A.G. Bodnar M. Ouellette M. Frolkis S.E. Holt C.P. Chiu G.B. Morin C.B. Harley J.W. Shay S. Lichtsteiner W.E. Wright (1998) ArticleTitleExtension of life-span by introduction of telomerase into normal human cells Science 279 349–352 Occurrence Handle9454332

    PubMed  Google Scholar 

  • C.M. Counter A.A. Avilion C.E. LeFeuvre N.G. Stewart C.W. Greider C.B. Harley S. Bacchetti (1992) ArticleTitleTelomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity EMBO J 11 1921–1929 Occurrence Handle1582420

    PubMed  Google Scholar 

  • C.M. Counter F.M. Botelho P. Wang C.B. Harley S. Bacchetti (1994) ArticleTitleStabilization of short telomeres and telomerase activity accompany immortalization of Epstein–Barr virus-transformed human B lymphocytes J. Virol. 68 3410–3414 Occurrence Handle8151802

    PubMed  Google Scholar 

  • C.M. Counter M. Meyerson E.N. Eaton L.W. Ellisen S.D. Caddle D.A. Haber R.A. Weinberg (1998) ArticleTitleTelomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase Oncogene 16 1217–1222 Occurrence Handle9528864

    PubMed  Google Scholar 

  • G. Gaudernack T. Buanes M. Meo S. Aamdal P. Brunsvig L.R. Braathen K. Kernland M.K. Gjertsen J.A. Eriksen M. Moller (2003) ArticleTitleClinical trials of a peptide based vaccine targeting telomerase Proc. Am. Soc. Clin. Oncol. 22 166

    Google Scholar 

  • E. Gilboa (1999) ArticleTitleThe makings of a tumor rejection antigen Immunity 11 263–70 Occurrence Handle10.1016/S1074-7613(00)80101-6 Occurrence Handle10514004

    Article  PubMed  Google Scholar 

  • D.A. Gross S. Graff-Dubois P. Opolon S. Cornet P. Alves A. Bennaceur-Griscelli O. Faure P. Guillaume H. Firat S. Chouaib F.A. Lemonnier J. Davoust I. Miconnet R.H. Vonderheide K. Kosmatopoulos (2004) ArticleTitleHigh vaccination efficiency of low-affinity epitopes in antitumor immunotherapy J. Clin. Invest. 113 425–433 Occurrence Handle10.1172/JCI200419418 Occurrence Handle14755339

    Article  PubMed  Google Scholar 

  • W.C. Hahn C.M. Counter A.S. Lundberg R.L. Beijersbergen M.W. Brooks R.A. Weinberg (1999a) ArticleTitleCreation of human tumour cells with defined genetic elements Nature 400 464–468 Occurrence Handle10.1038/22780

    Article  Google Scholar 

  • W.C. Hahn S.A. Stewart M.W. Brooks S.G. York E. Eaton A. Kurachi R.L. Beijersbergen J.H. Knoll M. Meyerson R.A. Weinberg (1999b) ArticleTitleInhibition of telomerase limits the growth of human cancer cells Nat. Med. 5 1164–1170 Occurrence Handle10.1038/13495

    Article  Google Scholar 

  • C. Harle-Bachor P. Boukamp (1996) ArticleTitleTelomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes Proc. Natl. Acad. Sci. USA 93 6476–6481 Occurrence Handle10.1073/pnas.93.13.6476 Occurrence Handle8692840

    Article  PubMed  Google Scholar 

  • C.B. Harley N.W. Kim K.R. Prowse S.L. Weinrich K.S. Hirsch M.D. West S. Bacchetti H.W. Hirte C.M. Counter C.W. Greider et al. (1994) ArticleTitleTelomerasecell immortality, and cancer Cold Spring Harb. Symp. Quant. Biol. 59 307–315 Occurrence Handle7587082

    PubMed  Google Scholar 

  • L. Harrington W. Zhou T. McPhail R. Oulton D.S. Yeung V. Mar M.B. Bass M.O. Robinson (1997) ArticleTitleHuman telomerase contains evolutionarily conserved catalytic and structural subunits Genes Dev. 11 3109–3115 Occurrence Handle9389643

    PubMed  Google Scholar 

  • A. Heiser M.A. Maurice D.R. Yancey D.M. Coleman P. Dahm J. Vieweg (2001a) ArticleTitleHuman dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors Cancer Res. 61 3388–3393

    Google Scholar 

  • A. Heiser M.A. Maurice D.R. Yancey N.Z. Wu P. Dahm S.K. Pruitt D. Boczkowski S.K. Nair M.S. Ballo E. Gilboa J. Vieweg (2001b) ArticleTitleInduction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA J. Immunol. 166 2953–2960

    Google Scholar 

  • B. Herbert A.E. Pitts S.I. Baker S.E. Hamilton W.E. Wright J.W. Shay D.R. Corey (1999) ArticleTitleInhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death Proc. Natl. Acad. Sci. USA 96 14276–14281 Occurrence Handle10.1073/pnas.96.25.14276 Occurrence Handle10588696

    Article  PubMed  Google Scholar 

  • K. Hiyama Y. Hirai S. Kyoizumi M. Akiyama E. Hiyama M.A. Piatyszek J.W. Shay S. Ishioka M. Yamakido (1995) ArticleTitleActivation of telomerase in human lymphocytes and hematopoietic progenitor cells J. Immunol. 155 3711–3715 Occurrence Handle7561072

    PubMed  Google Scholar 

  • K. Hung R. Hayashi A. Lafond-Walker C. Lowenstein D. Pardoll H. Levitsky (1998) ArticleTitleThe central role of CD4(+) T cells in the antitumor immune response J. Exp. Med. 188 2357–2368 Occurrence Handle10.1084/jem.188.12.2357 Occurrence Handle9858522

    Article  PubMed  Google Scholar 

  • E.M. Janssen E.E. Lemmens T. Wolfe U. Christen M.G. von Herrath S.P. Schoenberger (2003) ArticleTitleCD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes Nature 421 852–856 Occurrence Handle10.1038/nature01441 Occurrence Handle12594515

    Article  PubMed  Google Scholar 

  • N.W. Kim M.A. Piatyszek K.R. Prowse C.B. Harley M.D. West P.L. Ho G.M. Coviello W.E. Wright S.L. Weinrich J.W. Shay (1994) ArticleTitleSpecific association of human telomerase activity with immortal cells and cancer Science 266 2011–2015 Occurrence Handle7605428

    PubMed  Google Scholar 

  • A. Lev G. Denkberg C.J. Cohen M. Tzukerman K.L. Skorecki P. Chames H.R. Hoogenboom Y. Reiter (2002) ArticleTitleIsolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatability complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit Cancer Res. 62 3184–3194 Occurrence Handle12036932

    PubMed  Google Scholar 

  • K. Masutomi E.Y. Yu S. Khurts I. Ben-Porath J.L. Currier G.B. Metz M.W. Brooks S. Kaneko S. Murakami J.A. DeCaprio R.A. Weinberg S.A. Stewart W.C. Hahn (2003) ArticleTitleTelomerase maintains telomere structure in normal human cells Cell 114 241–253 Occurrence Handle10.1016/S0092-8674(03)00550-6 Occurrence Handle12887925

    Article  PubMed  Google Scholar 

  • M. Meyerson C.M. Counter E.N. Eaton L.W. Ellisen P. Steiner S.D. Caddle L. Ziaugra R.L. Beijersbergen M.J. Davidoff Q. Liu S. Bacchetti D.A. Haber R.A. Weinberg (1997) ArticleTitlehEST2, the putative human telomerase catalytic subunit geneis up-regulated in tumor cells and during immortalization Cell 90 785–795 Occurrence Handle9288757

    PubMed  Google Scholar 

  • B. Minev J. Hipp H. Firat J.D. Schmidt P. Langlade-Demoyen M. Zanetti (2000) ArticleTitleCytotoxic T cell immunity against telomerase reverse transcriptase in humans Proc. Natl. Acad. Sci. USA 97 4796–4801 Occurrence Handle10.1073/pnas.070560797 Occurrence Handle10759561

    Article  PubMed  Google Scholar 

  • S.K. Nair A. Heiser D. Boczkowski A. Majumdar M. Naoe J.S. Lebkowski J. Vieweg E. Gilboa (2000) ArticleTitleInduction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells Nat. Med. 6 1011–1017 Occurrence Handle10.1038/79519 Occurrence Handle10973321

    Article  PubMed  Google Scholar 

  • T.M. Nakamura G.B. Morin K.B. Chapman S.L. Weinrich W.H. Andrews J. Lingner C.B. Harley T.R. Cech (1997) ArticleTitleTelomerase catalytic subunit homologs from fission yeast and human Science 277 955–959

    Google Scholar 

  • S. Ramakrishnan U. Eppenberger H. Mueller Y. Shinkai R. Narayanan (1998) ArticleTitleExpression profile of the putative catalytic subunit of the telomerase gene Cancer Res. 58 622–625 Occurrence Handle9485011

    PubMed  Google Scholar 

  • S.A. Rosenberg (1997) ArticleTitleCancer vaccines based on the identification of genes encoding cancer regression antigens Immunol. Today 18 175–182 Occurrence Handle10.1016/S0167-5699(97)84664-6 Occurrence Handle9136454

    Article  PubMed  Google Scholar 

  • S.A. Rosenberg (2001) ArticleTitleProgress in human tumour immunology and immunotherapy Nature 411 380–384 Occurrence Handle10.1038/35077246 Occurrence Handle11357146

    Article  PubMed  Google Scholar 

  • A. Scardino D.A. Gross P. Alves J.L. Schultze S. Graff-Dubois O. Faure S. Tourdot S. Chouaib L.M. Nadler F.A. Lemonnier R.H. Vonderheide A.A. Cardoso K. Kosmatopoulos (2002) ArticleTitleHER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy J. Immunol. 168 5900–5906 Occurrence Handle12023395

    PubMed  Google Scholar 

  • R. Schroers X.F. Huang J. Hammer J. Zhang S.Y. Chen (2002) ArticleTitleIdentification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+ T-helper cells Cancer Res. 62 2600–2605 Occurrence Handle11980655

    PubMed  Google Scholar 

  • R. Schroers L. Shen L. Rollins C.M. Rooney K. Slawin G. Sonderstrup X.F. Huang S.Y. Chen (2003) ArticleTitleHuman telomerase reverse transcriptase-specific T-helper responses induced by promiscuous major histocompatability complex class II-restricted epitopes Clin. Cancer Res. 9 4743–4755 Occurrence Handle14581345

    PubMed  Google Scholar 

  • J.L. Schultze R.H. Vonderheide (2001) ArticleTitleFrom cancer genomics to cancer immunotherapy: toward second-generation tumor antigens Trends Immunol. 22 516–523 Occurrence Handle10.1016/S1471-4906(01)02015-4 Occurrence Handle11525943

    Article  PubMed  Google Scholar 

  • D.E. Speiser J.C. Cerottini P. Romero (2002) ArticleTitleCan hTERT peptide (540–548)-specific CD8 T cells recognize and kill tumor cells? Cancer Immun. 2 14 Occurrence Handle12747759

    PubMed  Google Scholar 

  • Z. Su J. Dannull P. Dahm B. Yang D. Coleman D. Yancey S. Sichi J. Higgins E. Gilboa J. Vieweg (2003a) ArticleTitleVaccination of patients with hormone-refractory prostate cancer using telomerase RNA transfected DC: results from a phase I clinical trial Blood 102S 11

    Google Scholar 

  • Z. Su J. Dannull A. Heiser D. Yancey S. Pruitt J. Madden D. Coleman D. Niedzwiecki E. Gilboa J. Vieweg (2003b) ArticleTitleImmunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells Cancer Res. 63 2127–2133

    Google Scholar 

  • B.J. Van den Eynde P. van der Bruggen (1997) ArticleTitleT cell defined tumor antigens Curr. Opin. Immunol. 9 684–693 Occurrence Handle10.1016/S0952-7915(97)80050-7 Occurrence Handle9368778

    Article  PubMed  Google Scholar 

  • A. Van Pel P. van der Bruggen P.G. Coulie V.G. Brichard B. Lethe B. van den Eynde C. Uyttenhove J.C. Renauld T. Boon (1995) ArticleTitleGenes coding for tumor antigens recognized by cytolytic T lymphocytes Immunol. Rev. 145 229–250 Occurrence Handle7590828

    PubMed  Google Scholar 

  • H. Vaziri S. Benchimol (1998) ArticleTitleReconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span Curr. Biol. 8 279–382 Occurrence Handle10.1016/S0960-9822(98)70109-5 Occurrence Handle9501072

    Article  PubMed  Google Scholar 

  • R.H. Vonderheide W.C. Hahn J.L. Schultze L.M. Nadler (1999) ArticleTitleThe telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes Immunity 10 673–679 Occurrence Handle10.1016/S1074-7613(00)80066-7 Occurrence Handle10403642

    Article  PubMed  Google Scholar 

  • R.H. Vonderheide K.S. Anderson W.C. Hahn M.O. Butler J.L. Schultze L.M. Nadler (2001b) ArticleTitleCharacterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase Clin. Cancer Res. 7 3343–3348

    Google Scholar 

  • R.H. Vonderheide S.M. Domchek J.L. Schultze D.J. George K.M. Hoar D.Y. Chen K.F. Stephans K. Masutomi M. Loda Z. Xia K.S. Anderson W.C. Hahn L.M. Nadler (2004) ArticleTitleVaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes Clin. Cancer Res. 10 828–839 Occurrence Handle14871958

    PubMed  Google Scholar 

  • R.H. Vonderheide J.L. Schultze K.S. Anderson B. Maecker M.O. Butler Z. Xia M.J. Kuroda M.S. von Bergwelt-Baildon M.M. Bedor K.M. Hoar D.R. Schnipper M.W. Brooks N.L. Letvin K.F. Stephans K.W. Wucherpgennig W.C. Hahn L.M. Nadler (2001a) ArticleTitleEquivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals Cancer Res. 61 8366–8370

    Google Scholar 

  • S. Yasumoto C. Kunimura K. Kikuchi H. Tahara H. Ohji H. Yamamoto T. Ide T. Utakoji (1996) ArticleTitleTelomerase activity in normal human epithelial cells Oncogene 13 433–439 Occurrence Handle8710384

    PubMed  Google Scholar 

  • X. Zhang V. Mar W. Zhou L. Harrington M.O. Robinson (1999) ArticleTitleTelomere shortening and apoptosis in telomere-inhibited human tumor cells Genes Dev. 13 2388–2399 Occurrence Handle10.1101/gad.13.18.2388 Occurrence Handle10500096

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA , 19104, USA

    Kunal P. Patel & Robert H. Vonderheide

Authors
  1. Kunal P. Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert H. Vonderheide
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert H. Vonderheide.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patel, K., Vonderheide, R. Telomerase as a tumor-associated antigen for cancer immunotherapy. Cytotechnology 45, 91–99 (2004). https://doi.org/10.1007/s10616-004-5132-2

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10616-004-5132-2

Keywords

Search

Navigation